Cardica, which designs and manufactures an automated anastomotic device to perform coronary artery bypass surgery, priced its offering of 3.5 million shares at $10 on Thursday night. The pricing came at the low end of the company's recently reduced price range of $10 to $12. AG Edwards and Allen & Company were the lead underwriters on the deal. The stock is expected to begin trading on the NASDAQ under the ticker CRDC on Friday.
